가슴 보형물 수술 (gaseum boheongmul susul — breast implant surgery) carries the same complication profile in Korea as anywhere in the world where it is performed at high volume. Two considerations are specific to the Korean context: the dominant surgical technique (double-plane), and the ghost surgery risk that all international patients must actively mitigate. This page covers both, plus the full complication reference data.
Breast Augmentation Complication Risk Reference Table
| Complication | Likelihood | Severity | Typical Onset | Recommended Action |
|---|---|---|---|---|
| Capsular Contracture (Grade III/IV) | 5–15% lifetime | Moderate–Severe | Months to years | Double-plane placement; antibiotic irrigation; no-touch technique |
| Implant Malposition | 2–5% | Moderate | Weeks to months | High-volume surgeon; confirmed pocket dissection technique |
| BIA-ALCL | <1 in 30,000 (textured) | Severe (rare) | Years | Avoid macro-textured implants; request MFDS certification |
| Infection | <2% | Moderate–Severe | Days to weeks | Prophylactic antibiotics; accredited facility |
| Seroma | 1–3% | Mild–Moderate | Days to weeks | Compression garment; drain if combined with lift |
| Haematoma | 1–3% | Moderate | Hours to days | Avoid NSAIDs pre-op; experienced surgeon |
| Implant Rupture (10-year) | ~10% silicone (modern) | Moderate | Years | Regular MRI monitoring from year 5–7 per guidelines |
KFDA vs FDA Implant Approval: What It Means for You
Korea’s regulatory body for medical devices is the MFDS (Ministry of Food and Drug Safety, 식품의약품안전처), previously known as KFDA. MFDS evaluates breast implants through a process broadly comparable to the US FDA’s 510(k) clearance or Premarket Approval (PMA) pathway — requiring biocompatibility testing, clinical safety data, and manufacturing quality standards.
Major breast implant brands available in Korea and their regulatory status:
- Mentor (J&J): MFDS-approved and FDA-approved
- Motiva (Establishment Labs): MFDS-approved; FDA-approved under PMA since 2021
- Bellagel (HansBiomed): MFDS-approved; not independently FDA-approved (Korean domestic brand)
- Allergan Natrelle (AbbVie): MFDS-approved and FDA-approved; note that macro-textured Biocell variants were voluntarily recalled by Allergan in 2019 following BIA-ALCL concerns
The practical action: confirm with your clinic the specific implant brand, model, and texture category they plan to use. Request that the implant’s approval status be stated in writing at consultation. At discharge, collect the implant card with the serial number — this is essential for both home-country medical records and implant recall monitoring.
Double-Plane as Korea’s Standard Technique
The double-plane technique is the dominant approach for breast augmentation at most Korean aesthetic clinics, particularly for patients with Asian body types characterised by less pre-existing breast tissue and tighter pectoral muscles.
In double-plane placement, the implant sits with the upper half beneath the pectoralis major muscle (submuscular) and the lower half beneath the breast gland (subglandular). This hybrid position:
- Reduces capsular contracture rates compared with fully subglandular placement (approximately 5–8% vs 8–15% in published data)
- Provides more natural-looking upper-pole slope vs fully submuscular placement, which can create an overly high, round appearance
- Allows the muscle to provide natural implant coverage in the upper pole without restricting lower-pole projection
Fully subglandular placement remains appropriate for some patients (sufficient pre-existing breast tissue, specific aesthetic goals) and is priced similarly. The key point: Korean surgeons routinely discuss pocket plane in consultation and adjust for individual anatomy — a surgeon who does not discuss this topic or who applies a single approach to all patients is not demonstrating the technical nuance that the double-plane technique requires.
Ghost Surgery: The Korea-Specific Risk and How to Prevent It
Ghost surgery (대리 수술, daeri susul — substitute surgery) is the illegal substitution of a different surgeon during a procedure, typically occurring when the patient is under general anaesthesia and cannot verify who is in the room. The practice was extensively documented in Korea in the 2010s and generated significant legislative and media attention.
The 2016 Act on Special Cases Concerning the Punishment of Specific Crimes was amended to specifically criminalise ghost surgery, requiring the primary consented surgeon to be present throughout the procedure. However, legislative prohibition and enforcement on the day of surgery are different things — the law does not physically prevent the practice, and verification by international patients, who often have no independent contacts in the clinic, is challenging.
Three protections that are effective:
1. Name on the consent form. The surgical consent form (수술동의서) must name the specific operating surgeon. A form that names only the clinic or leaves the surgeon field blank provides no legal protection and should be refused.
2. Face-to-face surgeon confirmation. Meet your surgeon in person at the consultation, confirm you recognise them at the pre-operative assessment, and request to meet them in the operating area before anaesthesia induction — a reasonable request that reputable clinics accommodate.
3. KHIDI registration. KHIDI-registered clinics treating international patients are subject to a code of conduct that explicitly prohibits ghost surgery. While not a guarantee, KHIDI registration adds an accountability layer that standalone, unregistered clinics lack.
How to Verify Your Korean Breast Surgeon
KSPRS board certification is verifiable through the public registry at plasticsurgery.or.kr. The search function is in Korean; provide your surgeon’s name to a Korean-speaking contact or coordinator and ask them to confirm the registration status and specialty listed.
Additionally:
- Confirm the surgeon’s stated annual case volume for breast augmentation specifically — ask directly at consultation. High-volume surgeons (100+ cases per year) are easier to verify through patient reviews and before/after portfolios.
- Request a video consultation before travel. A surgeon who will not video-consult before booking is less likely to be the primary point of clinical contact throughout your care.
- Ask whether the operating surgeon performs the anaesthesia induction or whether a separate anaesthesiologist is present. In accredited Korean facilities for general anaesthesia, a separate anaesthesiologist should be in attendance throughout — this is both a quality and a safety indicator.
What is ghost surgery and how common is it in Korea?
Ghost surgery refers to a different surgeon performing your procedure without your knowledge while you are under general anaesthesia. It became a high-profile scandal in Korea following documented cases and media investigations. South Korea passed legislation in 2016 requiring the consented primary surgeon to be present throughout surgery. Protect yourself by meeting your surgeon in person, confirming attendance in writing on the consent form, and choosing clinics that allow you to verify surgeon identity at the point of anaesthesia induction.
Are breast implants in Korea approved to the same standard as FDA-approved implants?
Korea's MFDS evaluates and approves breast implants to standards broadly comparable to FDA 510(k) or PMA requirements. Major implant brands sold in Korea — including Mentor, Motiva, and Bellagel — hold both MFDS and FDA or CE clearance. However, not every brand sold in Korea holds FDA approval. Ask your clinic to show you the MFDS approval certificate for the specific implant style they plan to use, and keep the implant serial number card for your home-country medical records.
What is capsular contracture and can I reduce my risk?
Capsular contracture is the hardening of the normal scar capsule that forms around any breast implant, occurring in grades I–IV. Grades III and IV (clinically significant hardening or pain) affect approximately 5–15% of patients over a lifetime. Risk is reduced by: double-plane or submuscular placement, use of smooth implants, intraoperative pocket irrigation with antibiotic solution (the 14-point plan protocol), and no-touch implant insertion technique. Ask your Korean surgeon specifically whether they use pocket irrigation and a no-touch sleeve — these are markers of contemporary technique.
Should I be worried about BIA-ALCL with Korean implants?
BIA-ALCL risk is associated specifically with macro-textured implants. The global incidence is estimated at fewer than 1 in 30,000 textured-implant cases, with most Korean clinics having moved to smooth or micro-textured devices. Motiva Ergonomix (micro-textured) implants used widely in Korea show no reported BIA-ALCL cases to date. Confirm with your clinic whether they use smooth, micro-textured, or macro-textured implants. If textured: ask about the specific MFDS/FDA classification and whether the brand has been associated with BIA-ALCL cases.